Management ChangeMay 13, 2026, 08:17 AM
ARS Pharma Appoints Donn Casale as President
AI Summary
ARS Pharmaceuticals, Inc. has appointed Donn Casale as its new President, effective June 1, 2026. Mr. Casale brings over 25 years of biopharmaceutical industry experience, including his most recent role as Chief Commercial Officer at Dynavax Technologies. He will receive an annual base salary of $575,000, an annual discretionary bonus of 45% of his base salary, and a stock option grant valued at $6,000,000.
Key Highlights
- ARS Pharmaceuticals appointed Donn Casale as President, effective June 1, 2026.
- Mr. Casale previously served as Chief Commercial Officer at Dynavax Technologies.
- His annual base salary is set at $575,000.
- He is eligible for an annual discretionary bonus of 45% of his base salary.
- He will receive a stock option grant valued at $6,000,000.
- Options vest 25% after one year, then monthly over 36 months.